logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Epalex announced it raised $4.26 Million in an initial filing from an offering of $8.5 Million

Epalex announced it raised $4.26 Million in an initial filing from an offering of $8.5 Million

10/14/22, 4:09 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgmountain view
Money raised
$4.26 million
Industry
health care
Round Type
seed

Company Info

Company
Epalex
Location
1049 el monte avenue, suite c 585
mountain view, california, united states
Additional Info
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful antiseizure medication that rapidly enters the brain and stops the seizure. The effect of the drug dissipates within minutes, allowing the patient to resume normal daily activity. The inhaler is also used to stop migraine attacks that are refractory to currently available migraine treatments.
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.

Related people

RH

BH

Sign up to get related executive contact information